Century Therapeutics, Inc. (IPSC) vs Q32 Bio Inc. (QTTB)
- Century Therapeutics, Inc. IPSC 1.68 +11.26%
- Q32 Bio Inc. QTTB 9.25 +4.52%
Century Therapeutics, Inc. and Q32 Bio Inc. are both Biotechnology companies. Century Therapeutics, Inc. and Q32 Bio Inc. are of similar size ($273.4M and $263.5M). Century Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 3.1×. Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against −307.3%. Across the 11 metrics below, Q32 Bio Inc. leads on 9 and Century Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | IPSC | QTTB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (49.65%) | 72.14% | (51.96%) |
| Return on assets | (38.41%) | 37.13% | (46.06%) |
| Return on invested capital | (64.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack